CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(5.63%)
USD 0.01
(5.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 105.67 Thousand | 109 Thousand | 116.29 Thousand | 125.33 Thousand | 72.24 Thousand | - |
| Gross Profit | -105.67 Thousand | -109 Thousand | -116.29 Thousand | -125.33 Thousand | -72.24 Thousand | - |
| Operating Expenses | 13.47 Million | 39.64 Million | 20.16 Million | 9.81 Million | 25.22 Million | 14.5 Million |
| Selling, General and Administrative Expenses | 10.69 Million | 15.46 Million | 11.69 Million | 3.35 Million | 18.85 Million | 7.66 Million |
| Research and Development Expenses | 2.78 Million | 2.43 Million | 3.94 Million | 2.29 Million | 2.03 Million | 1.07 Million |
| Other Expenses | - | 246.34 Billion | 770.6 Thousand | 264.73 Thousand | 250.39 Thousand | - |
| Cost and Expenses | 13.47 Million | 39.64 Million | 20.16 Million | 9.81 Million | 25.22 Million | 14.5 Million |
| Operating Income | -13.47 Million | -17.89 Million | -15.64 Million | -5.64 Million | -20.86 Million | -8.74 Million |
| Interest Expense | 44.83 | 26.66 Thousand | 186.2 Thousand | 1.08 Million | 185.14 Thousand | - |
| Income Tax Expense | -2.34 Million | 942.74 Thousand | 23.2 Thousand | 20.42 Thousand | 9496.00 | -1.00 |
| Earnings before Tax | -22.28 Million | -39.66 Million | -20.34 Million | -10.9 Million | -25.4 Million | -14.49 Million |
| Net Income | -19.93 Million | -38.72 Million | -20.32 Million | -12 Million | -25.39 Million | -14.49 Million |
| Earnings Per Share Basic | -52.60 | -387.26 | -247.86 | -255.46 | -875.66 | -1449.54 |
| Earnings Per Share Diluted | -52.59 | -387.18 | -246.32 | -251.32 | -874.45 | -1449.54 |
| Weighted Average Shares Outstanding | 379 Thousand | 100 Thousand | 82 Thousand | 47 Thousand | 29 Thousand | 10 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 379.08 Thousand | 100.02 Thousand | 82.51 Thousand | 47.77 Thousand | 29.04 Thousand | 10 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -22.13 Million | -17.78 Million | -20.04 Million | -5.52 Million | -20.79 Million | -8.72 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 166.03 Thousand | - | - | - |
| Cost of Revenue | 23.98 Thousand | 23.57 Thousand | 22.66 Thousand | 105.67 Thousand | 32.69 Thousand | 28.55 Thousand |
| Gross Profit | -23.98 Thousand | -23.57 Thousand | 143.37 Thousand | -105.67 Thousand | -32.69 Thousand | -28.55 Thousand |
| Operating Expenses | 1.82 Million | 2.06 Million | 1.22 Million | 22.23 Million | 12.59 Million | 3.66 Million |
| Selling, General and Administrative Expenses | 1.2 Million | 1.53 Million | 1.48 Million | - | 2.43 Million | 2.76 Million |
| Research and Development Expenses | 621.98 Thousand | 535.72 Thousand | 36.36 Thousand | - | 1.1 Million | 920.9 Thousand |
| Other Expenses | 1.86 Million | 1.03 Million | 527.33 Billion | 527.33 Billion | 132.88 Thousand | 131.46 Thousand |
| Cost and Expenses | 1.84 Million | 2.09 Million | 1.22 Million | 22.23 Million | 12.59 Million | 3.66 Million |
| Operating Income | -1.84 Million | -2.09 Million | -1.45 Million | -13.47 Million | -3.53 Million | -3.68 Million |
| Interest Expense | 11.36 Thousand | 16.44 Thousand | 10.03 Thousand | -44.82 Billion | 11.63 Thousand | 11.6 Thousand |
| Income Tax Expense | -1.00 | 4.00 | 4389.00 | 2.34 Million | 2.34 Million | -93.53 Thousand |
| Earnings before Tax | 11.78 Thousand | -1.06 Million | -1.23 Million | -22.28 Million | -12.61 Million | -3.68 Million |
| Net Income | 11.78 Thousand | -1.06 Million | -1.22 Million | -19.93 Million | -10.26 Million | -3.68 Million |
| Earnings Per Share Basic | 0.01 | -1.68 | -1.97 | - | -24.56 | -13.38 |
| Earnings Per Share Diluted | 0.01 | -1.68 | -1.97 | - | -24.53 | -13.37 |
| Weighted Average Shares Outstanding | 919.14 Thousand | 638.33 Thousand | 622 Thousand | 379 Thousand | 418 Thousand | 275 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 919.14 Thousand | 638.33 Thousand | 622.85 Thousand | 379.08 Thousand | 418.52 Thousand | 275.33 Thousand |
| Gross Margin | - | - | 0.86 | - | - | - |
| EBIT Margin | - | - | -8.61 | - | - | - |
| Profit Margin | - | - | -7.39 | - | - | - |
| EBITDA | -1.82 Million | -2.06 Million | -1.42 Million | - | -3.5 Million | -3.65 Million |
| Earnings Before Tax Margin | - | - | -8.75 | - | - | - |
BIT
PRG
MEDICAPQ
301019
605339
TRS